These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk]. von Schoultz B Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143 [No Abstract] [Full Text] [Related]
3. Landmark hormone replacement therapy study stopped after finding more harms than benefits. Rollins G Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323 [No Abstract] [Full Text] [Related]
4. Postmenopausal hormone replacement therapy: does the progestin make a difference? Fylstra DL J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600 [No Abstract] [Full Text] [Related]
5. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
6. Postmenopausal hormone therapy and breast cancer. Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723 [TBL] [Abstract][Full Text] [Related]
7. [After discontinuation of the Women's Health Initiative Study of hormone substitution. Should hormone replacement be stopped? (interview by Dr. Brigitte Moreano)]. Seifert-Klauss V MMW Fortschr Med; 2002 Jul; 144(29-30):16. PubMed ID: 12219606 [No Abstract] [Full Text] [Related]
8. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850 [No Abstract] [Full Text] [Related]
9. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use]. Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer and hormone-replacement therapy: the Million Women Study. Garton M Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985 [No Abstract] [Full Text] [Related]
14. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear]. von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053 [No Abstract] [Full Text] [Related]
15. [Estrogen replacement therapy and breast cancer]. Bakken K; Alsaker E; Eggen AE; Lund E Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147 [TBL] [Abstract][Full Text] [Related]
16. [Against medicalizing the postmenopause with HRT]. Guyot B Gynecol Obstet Fertil; 2008 Jan; 36(1):104-9. PubMed ID: 18248840 [No Abstract] [Full Text] [Related]
17. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233 [No Abstract] [Full Text] [Related]
18. Postmenopausal hormone therapy and breast cancer: what is the problem? Kenemans P Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112 [TBL] [Abstract][Full Text] [Related]
19. [Estrogen substitution following the menopause and the risk of breast cancer; the importance of endogenous risk factors]. Russchen CJ Ned Tijdschr Geneeskd; 1992 Jul; 136(28):1337-9. PubMed ID: 1635595 [No Abstract] [Full Text] [Related]
20. [Postmenopausal hormone replacement therapy--is there a cause of worry?]. Skouby SO; Wilken-Jensen C; Jespersen J; Pedersen AT; Ottesen BS Ugeskr Laeger; 2002 Aug; 164(34):3974-5. PubMed ID: 12212482 [No Abstract] [Full Text] [Related] [Next] [New Search]